Stock PAUSHAKLTD6 PAUSHAK LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Financials Paushak Limited

Equities

PAUSHAKLTD6

INE111F01016

Specialty Chemicals

Market Closed - Bombay S.E.
Other stock markets
 06:00:49 2024-04-29 am EDT 		5-day change 1st Jan Change
5,172 INR +0.84% Intraday chart for Paushak Limited +3.87% -14.77%
Apr. 01 Paushak Limited Announces Cessation of Amit Goradia and Vijay Gandhi as an Independent Directors CI
Feb. 02 Paushak Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023 CI

Valuation

Fiscal Period: March 2018 2019 2020 2021 2022 2023
Capitalization 1 4,127 6,250 5,332 25,756 32,038 19,162
Enterprise Value (EV) 1 4,108 5,898 4,676 25,317 31,610 18,456
P/E ratio 19.2 x 16.1 x 15.3 x 69.1 x 85.2 x 35.5 x
Yield 0.23% 0.25% 0.35% 0.07% 0.12% 0.28%
Capitalization / Revenue 3.98 x 4.48 x 3.87 x 18.3 x 21.3 x 9.02 x
EV / Revenue 3.97 x 4.22 x 3.39 x 18 x 21.1 x 8.69 x
EV / EBITDA 13.6 x 14.6 x 10.9 x 50.1 x 58.1 x 24.5 x
EV / FCF 328 x 63.5 x 21.9 x -146 x -152 x 131 x
FCF Yield 0.31% 1.58% 4.56% -0.69% -0.66% 0.76%
Price to Book 3.65 x 3.52 x 2.35 x 9.48 x 10.5 x 5.42 x
Nbr of stocks (in thousands) 3,207 3,082 3,082 3,082 3,082 3,082
Reference price 2 1,287 2,028 1,730 8,357 10,395 6,217
Announcement Date 7/4/18 7/5/19 7/1/20 6/29/21 7/8/22 7/4/23
1INR in Million2INR
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: March 2018 2019 2020 2021 2022 2023
Net sales 1 1,036 1,396 1,379 1,410 1,501 2,123
EBITDA 1 301.3 404.9 428.7 505.4 544 752.8
EBIT 1 267.4 366.3 384.9 455.8 453.7 618.6
Operating Margin 25.81% 26.23% 27.9% 32.32% 30.23% 29.13%
Earnings before Tax (EBT) 1 288.7 489.9 453.7 515.9 502.8 722.2
Net income 1 214.7 389.6 349.1 373 376.1 540.1
Net margin 20.72% 27.9% 25.31% 26.45% 25.06% 25.43%
EPS 2 66.95 125.6 113.3 121.0 122.0 175.2
Free Cash Flow 1 12.53 92.95 213.4 -173.5 -208.5 141
FCF margin 1.21% 6.66% 15.47% -12.3% -13.89% 6.64%
FCF Conversion (EBITDA) 4.16% 22.96% 49.79% - - 18.73%
FCF Conversion (Net income) 5.84% 23.86% 61.13% - - 26.11%
Dividend per Share 2 3.000 5.000 6.000 6.000 12.00 17.50
Announcement Date 7/4/18 7/5/19 7/1/20 6/29/21 7/8/22 7/4/23
1INR in Million2INR
Estimates

Balance Sheet Analysis

Fiscal Period: March 2018 2019 2020 2021 2022 2023
Net Debt 1 - - - - - -
Net Cash position 1 18.2 352 656 440 428 706
Leverage (Debt/EBITDA) - - - - - -
Free Cash Flow 1 12.5 93 213 -173 -208 141
ROE (net income / shareholders' equity) 21.9% 26.8% 17.2% 15% 13% 16.4%
ROA (Net income/ Total Assets) 14% 12.8% 9.94% 9.52% 8.16% 9.9%
Assets 1 1,533 3,050 3,511 3,919 4,611 5,457
Book Value Per Share 2 353.0 576.0 737.0 881.0 991.0 1,148
Cash Flow per Share 2 0.1800 1.770 2.590 0.5900 0.2000 1.690
Capex 1 56.4 104 171 558 483 171
Capex / Sales 5.45% 7.43% 12.36% 39.55% 32.15% 8.07%
Announcement Date 7/4/18 7/5/19 7/1/20 6/29/21 7/8/22 7/4/23
1INR in Million2INR
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Other Specialty Chemicals

1st Jan change Capi.
PAUSHAK LIMITED Stock Paushak Limited
-14.77% 190M
ECOLAB INC. Stock Ecolab Inc.
+11.62% 63.22B
SIKA AG Stock Sika AG
-3.51% 46.34B
GIVAUDAN SA Stock Givaudan SA
+13.09% 39.97B
FUJIFILM HOLDINGS CORPORATION Stock Fujifilm Holdings Corporation
+17.83% 25.46B
EMS-CHEMIE HOLDING AG Stock EMS-CHEMIE HOLDING AG
+8.37% 18.68B
CELANESE CORPORATION Stock Celanese Corporation
+0.86% 17.24B
POSCO FUTURE M CO., LTD. Stock Posco Future M Co., Ltd.
-20.33% 15.81B
SYMRISE AG Stock Symrise AG
+0.36% 14.9B
ALBEMARLE CORPORATION Stock Albemarle Corporation
-13.47% 13.74B
Other Specialty Chemicals
  1. Stock Market
  2. Equities
  3. PAUSHAKLTD6 Stock
  4. Financials Paushak Limited